Call Options

7 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$439.2 - $524.63 $1.1 Million - $1.31 Million
-2,500 Reduced 55.56%
2,000 $1.02 Million
Q1 2024

May 14, 2024

SELL
$472.6 - $545.42 $15.6 Million - $18.1 Million
-33,100 Reduced 88.03%
4,500 $2.23 Million
Q4 2023

Feb 13, 2024

BUY
$509.47 - $552.97 $1.32 Million - $1.44 Million
2,600 Added 7.43%
37,600 $19.8 Million
Q3 2023

Nov 13, 2023

BUY
$447.75 - $510.93 $6.72 Million - $7.66 Million
15,000 Added 75.0%
35,000 $17.6 Million
Q2 2023

Aug 14, 2023

BUY
$458.49 - $526.23 $9.17 Million - $10.5 Million
20,000 New
20,000 $9.61 Million
Q4 2022

Feb 14, 2023

BUY
$498.86 - $555.15 $7.48 Million - $8.33 Million
15,000 Added 150.0%
25,000 $13.3 Million
Q3 2022

Nov 14, 2022

BUY
$501.24 - $549.95 $5.01 Million - $5.5 Million
10,000 New
10,000 $5.05 Million

Others Institutions Holding UNH

About UNITEDHEALTH GROUP INC


  • Ticker UNH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Healthcare Plans
  • Shares Outstandng 935,382,976
  • Market Cap $526B
  • Description
  • UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized empl...
More about UNH
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.